12/22
08:02 am
tlx
Telix Pharmaceuticals (NASDAQ:TLX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Telix Pharmaceuticals (NASDAQ:TLX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
12/14
09:02 pm
tlx
Telix Pharmaceuticals (NASDAQ:TLX) is now covered by analysts at Royal Bank Of Canada. They set a "sector perform" rating on the stock.
Medium
Report
Telix Pharmaceuticals (NASDAQ:TLX) is now covered by analysts at Royal Bank Of Canada. They set a "sector perform" rating on the stock.
12/14
09:02 pm
tlx
Telix Pharmaceuticals (NASDAQ:TLX) is now covered by analysts at Royal Bank Of Canada. They set a "sector perform" rating on the stock.
Medium
Report
Telix Pharmaceuticals (NASDAQ:TLX) is now covered by analysts at Royal Bank Of Canada. They set a "sector perform" rating on the stock.
12/14
08:11 pm
tlx
Telix Pharmaceuticals initiated with a Sector Perform at RBC Capital
Medium
Report
Telix Pharmaceuticals initiated with a Sector Perform at RBC Capital
12/14
08:11 pm
tlx
Telix Pharmaceuticals initiated with a Sector Perform at RBC Capital
Medium
Report
Telix Pharmaceuticals initiated with a Sector Perform at RBC Capital